Familial Dysautonomia Completed Phase 3 Trials for Salbutamol (DB01001)

Also known as: Riley-Day syndrome / Dysautonomia, Familial / Familial dysautonomia [Riley-Day] / HSAN III

IndicationStatusPhase
DBCOND0048634 (Familial Dysautonomia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01987219The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial DysautonomiaTreatment